C4 Therapeutics grants new hire 85,480 options
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
C4 Therapeutics (Nasdaq: CCCC) disclosed an inducement grant of non-qualified stock options covering 85,480 common shares to a newly hired employee. The options carry an exercise price equal to the closing price on the grant date and vest over four years, with 25% vesting on the first anniversary and the remaining 36 equal monthly installments contingent on continued employment.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.